Navigation Links
Minneapolis Heart Institute Foundation welcomes Europace publication of Optim™ lead insulation paper
Date:8/21/2012

MINNEAPOLIS, MN August 21, 2012 The Minneapolis Heart Institute Foundation, an international leader in cardiovascular research, today announces the online publication of a study in EP Europace that raises serious concerns about St. Jude Medical defibrillator leads. The study found that a new copolymer of silicone and polyurethane (Optim) might not prevent insulation abrasions that can result in electronic malfunction. The paper is authored by Foundation researchers Robert Hauser, Raed Abdelhadi, Deepa McGriff and Linda Retel, and it is another in a series of Foundation publications that have reported significant problems with defibrillator leads, including recalled Riata and Riata ST leads from St. Jude Medical (SJM).

Defibrillators are implanted in patients to prevent sudden cardiac death.

Defibrillator leads deliver energy to the heart in order to stop abnormal, rapid heartbeats that can cause blackouts and death. These leads must be able to function properly during years of service in the body.

The paper "Failure of a Novel Silicone-Polyurethane Copolymer (Optim) to Prevent ICD Lead Insulation Abrasions" appears on the journal's web site and is available at http://europace.oxfordjournals.org/content/current.

"Our paper presents data that suggest Riata ST Optim and Durata ICD leads may not be adequately protected from insulation abrasions caused by friction with the pulse generator can or other leads in the heart," stated Dr. Hauser. "We need studies to determine the incidence of these failures and the implications for patients. At this time we do not believe that patients should be unduly concerned or their leads replaced. We do believe that patients with these leads should be evaluated regularly, as recommended by their physicians."

This study follows on the heels of a recent FDA order that St. Jude Medical launch new studies focusing on the performance of its Riata and Duranta defibrillator leads. '/>"/>

Contact: Steve Goodyear
sgoodyear@mhif.org
612-863-1658
Minneapolis Heart Institute Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Former Vikings and NFL Greats Tackle Sleep Apnea at Upcoming Minneapolis Event
2. Close Relatives Early Death May Raise Your Heart Risk: Study
3. Newer Psoriasis Drugs May Lower Heart Attack Risk for Patients
4. New heart attack definition to be launched at ESC Congress 2012 topics: Myocardial disease
5. Your Blood Type May Boost Your Heart Risk, Study Finds
6. A vaccine for heart disease? La Jolla Institute discovery points up this possibility
7. Strategy May Help ER Docs Spot Heart Attacks Within an Hour
8. Statins Heart Benefits Outweigh Diabetes Risk: Study
9. Mechanical Device Helps Kids Waiting for Heart Transplant
10. Underinsured Heart Disease Patients Die Sooner, Study Finds
11. Some Improvement in Heart Risk Factors for Americans: CDC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 The Journal of Parasitology – ... computer software, it creates questions of ethics. For scientific ... an already published case shows, scientific publications need clear ... The Journal of Parasitology features a commentary ... 2004 article published in the Journal of the New ...
(Date:6/19/2013)... international study led by researchers at The University of ... continues to show remarkable promise for the treatment of ... most recent interim findings of the 18-center Phase 2 ... Journal of Medicine . Previous interim findings were presented ... Hematology Annual Meeting and Exposition. , Unprecedented ...
(Date:6/19/2013)... in the June 19 online edition of the journal ... from the University of California, San Diego School of ... place when cardiac regeneration occurs in zebrafish after cardiac ... cell lines in the heart are more plastic, or ... thought. , More importantly, the research reveals a novel ...
(Date:6/19/2013)... Ore. A new understanding of the genetic process ... diagnosis of potentially dangerous lesions for some women, and ... anti-viral therapies in certain cases suggesting they could ... , The analysis provides a clearer picture of the ... human papillomavirus sometimes leads to chronic infection and, in ...
(Date:6/19/2013)... Iowa study reveals significant disparities between minority and ... abuse treatment programs. Moreover, these disparities vary widely ... suggest that for most states there,s something amiss," ... and biostatistics. "There are strong racial and ethnic ... substance abuse treatment programs successfully, and those disparities ...
Breaking Medicine News(10 mins):Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2Health News:Genetics of cervical cancer raise concern about antiviral therapy in some cases 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3
... Dr. Sanjay Gupta, CNN chief medical correspondent, author and ... "Compelling Conversations" speaker series. Gupta will speak at ... , A leader in the national dialogue on ... shows "American Morning" and "House Call with Sanjay Gupta." ...
... As health care moves to the forefront of the national ... health of the population and the success or failure of ... social factors as it does on doctors, facilities, or drugs. ... are co-editors of a new collection of essays that analyze ...
... the Yerkes National Primate Research Center, Emory University, ... at the Society for Neuroscience,s 39th annual meeting ... is a representation of the neuroscience research Yerkes ... ongoing research and scientific resources available at the ...
... 16, 2009 MedImmune announced today it will present ... 2009 National Conference & Exhibition that add to the ... respiratory syncytial virus (RSV) on children, as well as ... RSV becoming more widespread this time of year, it ...
... to 17 centers for lax reporting of procedure-related adverse ... The percentage of patients who experience serious quality-of-life problems ... U.S. Food and Drug Administration, which has also issued ... weren,t properly reporting problems with the procedure. , The ...
... may be enough, researchers say , FRIDAY, Oct. ... question the increasing use of invasive procedures as first-line ... of blood vessels in and around the kidneys. , ... to detect, which has led to increased use of ...
Cached Medicine News:Health News:CNN Medical Correspondent Sanjay Gupta to Speak at Bunker Hill Community College 2Health News:Health care is only part of the puzzle: Social scientists analyze society's health and success 2Health News:Health care is only part of the puzzle: Social scientists analyze society's health and success 3Health News:Yerkes researchers present at 39th Annual Society for Neuroscience Conference 2Health News:Yerkes researchers present at 39th Annual Society for Neuroscience Conference 3Health News:Yerkes researchers present at 39th Annual Society for Neuroscience Conference 4Health News:Yerkes researchers present at 39th Annual Society for Neuroscience Conference 5Health News:MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition 2Health News:MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition 3Health News:New FDA Study Seeks Feedback on Lasik Surgery 2Health News:Docs May Be Overdoing Some Invasive Procedures 2
(Date:6/19/2013)... , June 19, 2013 DST Health Solutions, ... services to health plans, integrated delivery systems, and health ... Medical Drug Management Service (MDMS) has jumped significantly. ... and automate the pricing of medical prescription drug claims, ... by automating their medical drug claims processes. As specialty ...
(Date:6/19/2013)... CARLSBAD, Calif. , June 19, 2013 /PRNewswire/ ... ) today announces a licensing agreement granting Suzhou ... develop and manufacture siRNA therapeutics in ... technology.  Ribo will formulate proprietary siRNA molecules in ... platform designed to address human diseases with high ...
(Date:6/19/2013)... June 19, 2013  It may seem like an odd ... breast cancer. But these were two of the most talked ... Annual Meeting & Expo that just convened in ... this focus by some of the top internal medicine experts ... with new research that can not only save lives, but ...
Breaking Medicine Technology:Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4
... SAN DIEGO, May 26, 2011 Volcano Corporation ... following statement: Earlier this year, the ... a wholly-owned subsidiary of St. Jude Medical, that ... misappropriated LightLab,s confidential information in connection for use ...
... YORK, May 26, 2011 A new prostate cancer ... Medicine comparing surgical treatment to "watchful waiting" ... cancer and currently debating their treatment options. ... the most commonly offered clinical options for early prostate ...
Cached Medicine Technology:Statement From Volcano Corporation on Latest St. Jude Lawsuit 2Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 2Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 3
Fulgurating Electrode, 3 F...
... The ACMI USA Series ACN-2 Flexible CystoNephroscope ... It is ideal for office practice. The ... accommodates a full range of operating instruments ... outer diameter, and beveled, UltraGlide covered tip ...
Inquire...
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: